Efficacy and mechanism of action of the proteasome inhibitor PS-341 in T-cell lymphomas and HTLV-I associated adult T-cell leukemia/lymphoma
✍ Scribed by Nasr, Rihab; El-Sabban, Marwan E; Karam, José-Antonio; Dbaibo, Ghassan; Kfoury, Youmna; Arnulf, Bertrand; Lepelletier, Yves; Bex, Françoise; de Thé, Hugues; Hermine, Olivier
- Book ID
- 110069274
- Publisher
- Nature Publishing Group
- Year
- 2004
- Tongue
- English
- Weight
- 486 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0950-9232
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Most previous studies aimed at estimating the number of human T‐cell leukemia virus type‐1 (HTLV‐1) carriers in endemic areas have been based on seroprevalence rates in blood donors; however, this may result in underestimation because of the healthy donor effect. People who have health
Patterns of HTLV-I infection among family members
An epidemiological study was performed in French Guiana (population I 15,000) to determine the prevalence and incidence of adult T-cell leukemia/lymphoma (ATL) associated with human T-cell leukemia/lymphoma virus type I (HTLV-I). From January 1990 to December 1993, all suspected cases of ATL were en